ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Insmed Incorporated clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 52 studies whose lead sponsor is Insmed Incorporated or the company grouped under it. 8 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 10, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Compare Insmed with Merck and United Therapeutics →

Pipeline: 3 programs

Each counted once: 3 with a study Insmed Incorporated leads registered in the last two years.

  • Phase 1
  • Phase 3

The 2 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Insmed Incorporated’s own registered studies; Insmed Incorporated’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Insmed Incorporated’s studies test, most open studies first — 8 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

4 of Insmed Incorporated’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 1N’26
  2. 1D
  3. J’27
  4. 1F
  5. 1M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add all 4 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 19, 2026.

All 52 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now815%Recruiting 7 · Not yet recruiting 1
  • Under way, not recruiting24%
  • Completed3669%
  • Stopped early48%Terminated 3 · Withdrawn 1
  • Status unknown or other24%Approved for marketing 1 · Available 1

Phase

Where

  • United States38
  • Germany15
  • Spain14
  • Belgium13
  • Italy13
  • United Kingdom12

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 826

By the year each study started; 3 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Insmed Incorporated.

  • Insmed Incorporated
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    50 studies
  • Insmed Gene Therapy LLC
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →

Studies

Recruiting first, then most recently updated. Showing 50 of 52. Browse all 52 →